The ROS inhibitor NAC recovered the MECO-caused caspases 8/9 activation (Figure 7B,D), suggesting that MECO causes ROS-mediated caspases 8/9 activation in oral cancer cells. Here, CASP8 is linked to lip and oral cavity carcinoma.